Nimish P. Shah, 10% Owner at KalVista Pharmaceuticals, Inc. (KALV), bought 172,096 shares at $14.70 ($2.5M) on 2024-02-08, disclosed to the SEC on 2024-02-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.74 | 4,474 | $66K | 2.6% |
| 2 | $14.74 | 4,474 | $66K | 2.6% |
| 3 | $14.56 | 51,827 | $755K | 30.0% |
| 4 | $14.56 | 51,827 | $755K | 30.0% |
| 5 | $14.70 | 29,747 | $437K | 17.4% |
| 6 | $14.70 | 29,747 |
| $437K |
| 17.4% |
| Total | $14.62 avg | 172,096 | $2.5M | 100% |
| Filing → |
| TCDA | BUY | 2022-10-17 | $4.1M | — | Filing → |
| TCDA | BUY | 2022-10-11 | $2.6M | — | Filing → |
| TIL | BUY | 2021-03-25 | $6.0M | — | Filing → |